Experienced in Primary Lymphoma of the Brain

Aristine C. Cheng

7 Chung Shan South Road, 
TPQ, TW 
Experienced in Primary Lymphoma of the Brain
7 Chung Shan South Road, 
TPQ, TW 
OverviewLocationsClinical Research

Overview

Aristine Cheng practices in Taiwan. Cheng is rated as an Experienced expert by MediFind in the treatment of Primary Lymphoma of the Brain. Their top areas of expertise are Hepatitis A, Sepsis, Multisystem Inflammatory Syndrome in Children (MIS-C), and Pulmonary Alveolar Proteinosis.

Their clinical research consists of co-authoring 107 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Primary Lymphoma of the Brain.

Locations

7 Chung Shan South Road, TPQ, Taiwan
Other Locations
No.7 Chung Shan South Road, 100, TPQ, Taiwan
No. 7 Chung Shan South Road, TPQ 10002, Taiwan
Hsinchu Branch, Hsinchu, TNQ, Taiwan
21, Nanya South Road, Nanya, TPQ, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Prospective, Therapeutic Drug Monitoring Study of Reduced-Dose Efavirenz (400 mg) Plus Tenofovir Disoproxil Fumarate (TDF) and Lamivudine in a Fixed-Dose Combination Tablet (Combo) for Patients Receiving Co-Formulated TDF, Emtricitabine and Efavirenz (Atripla) With Viral Suppression in Taiwan
Prospective, Therapeutic Drug Monitoring Study of Reduced-Dose Efavirenz (400 mg) Plus Tenofovir Disoproxil Fumarate (TDF) and Lamivudine in a Fixed-Dose Combination Tablet (Combo) for Patients Receiving Co-Formulated TDF, Emtricitabine and Efavirenz (Atripla) With Viral Suppression in Taiwan
Enrollment Status: Completed
Publish Date: February 07, 2020
Intervention Type: Drug
Study Phase: Phase 3

107 Total Publications

Optimizing macrolide resistance detection for Mycobacterium abscessus: a potential low-cost, time-saving alternative.
Optimizing macrolide resistance detection for Mycobacterium abscessus: a potential low-cost, time-saving alternative.
Journal: Microbiology spectrum
Published: September 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Cheng's expertise for a condition
ConditionClose
      View All 30 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile